Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MC2-01 Cream in Chinese Subjects With Plaque Psoriasis
NCT07357831Phase 3Completed
- Sponsor
- Huadong Medicine
- Start
- Dec 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of calcipotriol + betamethasone in plaque psoriasis, sponsored by Huadong Medicine. Started Dec 2025; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07357831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07357831.